1. Kuronen, T., Peltola, H., Nors, T., Haque, N., Mäkelä, P. H. Adverse reactions and endotoxin content of polysaccharide vaccines. Dev. Biol. Stand. 34 (1977) 117–125.
2. Borgono, J. M., McLean, A. A., Vella, P. P., Woodhour, A. F., Canepa, I., Davidson, W. L., Hilleman, M. R. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc. Soc. Exp. Biol. Med. 157 (1978) 148–154.
3. Peltola, H., Käyhty, H., Sivonen, A., Mäkelä, P. H. TheHaemophilus type b capsular polysaccharide vaccine in children. A double-blind field study of 100,000 vaccinees three months to five years of age in Finland. Pediatrics 60 (1977) 730–737.
4. Peltola, H., Mäkelä, P. H., Käyhty, H., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O. V., Pettay, O., Karanko, V., Ahvonen, P., Sarna, S. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297 (1977) 686–691.
5. Landesman, S. H., Schiffman, G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev. Inf. Dis. 3 (1981) 184–197.